- Home
- RGCO vs XGN Comparison
RGCO vs XGN Comparison
Compare RGCO & XGN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- RGCO
- XGN
- Stock Information
- Founded
- RGCO 1912
- XGN 2002
- Country
- RGCO United States
- XGN United States
- Employees
- RGCO N/A
- XGN N/A
- Industry
- RGCO Oil & Gas Production
- XGN Medical Specialities
- Sector
- RGCO Utilities
- XGN Health Care
- Exchange
- RGCO Nasdaq
- XGN Nasdaq
- Market Cap
- RGCO 221.2M
- XGN 253.9M
- IPO Year
- RGCO N/A
- XGN 2019
- Fundamental
- Price
- RGCO $20.83
- XGN $9.54
- Analyst Decision
- RGCO
- XGN Strong Buy
- Analyst Count
- RGCO 0
- XGN 6
- Target Price
- RGCO N/A
- XGN $13.33
- AVG Volume (30 Days)
- RGCO 9.4K
- XGN 368.1K
- Earning Date
- RGCO 11-18-2025
- XGN 11-04-2025
- Dividend Yield
- RGCO 3.97%
- XGN N/A
- EPS Growth
- RGCO 5.90
- XGN N/A
- EPS
- RGCO 1.32
- XGN N/A
- Revenue
- RGCO $94,120,500.00
- XGN $63,599,000.00
- Revenue This Year
- RGCO $19.22
- XGN $22.50
- Revenue Next Year
- RGCO $2.97
- XGN $14.75
- P/E Ratio
- RGCO $15.78
- XGN N/A
- Revenue Growth
- RGCO 12.04
- XGN 14.08
- 52 Week Low
- RGCO $19.06
- XGN $2.43
- 52 Week High
- RGCO $23.82
- XGN $12.23
- Technical
- Relative Strength Index (RSI)
- RGCO 40.60
- XGN 27.66
- Support Level
- RGCO $20.71
- XGN $9.58
- Resistance Level
- RGCO $21.17
- XGN $11.92
- Average True Range (ATR)
- RGCO 0.31
- XGN 0.47
- MACD
- RGCO -0.02
- XGN -0.29
- Stochastic Oscillator
- RGCO 9.50
- XGN 9.70
About RGCO RGC Resources Inc.
RGC Resources Inc is involved in the business of distribution and sale of natural gas to residential, commercial, and industrial customers within its service territory in Roanoke, Virginia, and its surrounding localities. The company also provides certain non-regulated services. The company relies on multiple interstate pipelines to transport natural gas. The company operates in three segments: Gas Utility, which is the key revenue generator; Investment in Affiliates this segment reflects the income generated through the activities of the Company's investment in MVP and Southgate projects and Parent & Other including the unregulated activities of the Company as well as certain corporate eliminations.
About XGN Exagen Inc.
Exagen Inc is a commercial-stage diagnostics company committed to addressing the unmet need for the accurate diagnosis and monitoring of patients affected by autoimmune rheumatic diseases. It currently markets ten testing products under its Avise brand to provide an accurate, timely, and differential diagnosis and to optimize the treatment of ARDs. It markets and sells solutions to community rheumatologists.